Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05172089 · ClinicalTrials.gov registry record

Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence

A clinical trial of Diabetic Foot and Diabetic Foot Infection, sponsored by University of Pittsburgh.

Recruiting
Registry status
405
Enrollment target
2
Study locations

NCT05172089 is a study of Diabetic Foot and Diabetic Foot Infection that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 405 participants, below the 10,328-participant average among 30 other Diabetic Foot trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05172089, a study of Diabetic Foot and Diabetic Foot Infection, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
405 participants
Enrollment target
2
Study locations

Study Summary

This work is based on DFU patients, seeks to conduct a fully powered clinical study testing i) If DFU with a history of biofilm infection closes with deficient barrier function. ii) whether such functionally deficient wound closure, manifested as high TEWL, is associated with greater wound recurrence. The primary parent study will also address molecular mechanisms implicated in biofilm-induced loss of skin epithelial barrier integrity in DFU patients.

Study Locations (2)

Arizona

  • University of Arizona - Tucson

Pennsylvania

  • UPMC Wound Healing Services at UPMC Passavant - Cranberry Township

Trial Details

FieldValue
Enrollment Target 405 participants
Start Date 2024-04-02
Est. Completion 2029-06-27

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05172089

The ClinicalTrials.gov registry entry for NCT05172089 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,328-participant average among 30 other Diabetic Foot trials with a reported enrollment target (96% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 0 interventions.

NCT05172089 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05172089 about?

NCT05172089 is a clinical study titled "Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence". This work is based on DFU patients, seeks to conduct a fully powered clinical study testing i) If DFU with a history of biofilm infection closes with deficient barrier function. ii) whether such functionally deficient wound closure, manifested as high TEWL, is associated with greater wound recurrenc...

What is the current status of trial NCT05172089?

This trial is currently recruiting. The enrollment target is 405 participants. The study started on 2024-04-02. Estimated completion is 2029-06-27.

What conditions does trial NCT05172089 study?

This clinical trial studies the following conditions: Diabetic Foot, Diabetic Foot Infection, Chronic Wounds, Biofilm Infection, Trans-epidermal Water Loss (TEWL).

Who is sponsoring clinical trial NCT05172089?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05172089 being conducted?

This trial has 2 study locations across Arizona, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.